NasdaqCM:LQDAPharmaceuticals
Assessing Liquidia (LQDA) Valuation After Strong Multi‑Year Share Price Momentum
Recent share performance and business context
With no single headline event driving attention, Liquidia (LQDA) is drawing interest after a recent share price move. This is prompting a closer look at how its current valuation lines up with its rare disease portfolio.
See our latest analysis for Liquidia.
The latest move to a share price of US$36.77 comes after a 9.53% 1 month share price return and a 17.10% year to date share price return, set against a very large 5 year total shareholder...